Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Robert Sackstein, M.D.,Ph.D.

Concepts

This page shows the publications Robert Sackstein has written about Bone Marrow Cells.
Connection Strength

0.852
  1. Fulfilling Koch's postulates in glycoscience: HCELL, GPS and translational glycobiology. Glycobiology. 2016 06; 26(6):560-70.
    View in: PubMed
    Score: 0.339
  2. The bone marrow is akin to skin: HCELL and the biology of hematopoietic stem cell homing. J Investig Dermatol Symp Proc. 2004 Sep; 9(3):215-23.
    View in: PubMed
    Score: 0.153
  3. A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proc Natl Acad Sci U S A. 2000 Dec 05; 97(25):13841-6.
    View in: PubMed
    Score: 0.118
  4. A Glycovariant of Human CD44 is Characteristically Expressed on Human Mesenchymal Stem Cells. Stem Cells. 2017 04; 35(4):1080-1092.
    View in: PubMed
    Score: 0.090
  5. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A. 2007 Mar 27; 104(13):5431-6.
    View in: PubMed
    Score: 0.046
  6. G-CSF induces E-selectin ligand expression on human myeloid cells. Nat Med. 2006 Oct; 12(10):1185-90.
    View in: PubMed
    Score: 0.044
  7. A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses. J Immunol. 2001 Nov 15; 167(10):5531-4.
    View in: PubMed
    Score: 0.031
  8. differential L-selectin binding activities of human hematopoietic cell L-selectin ligands, HCELL and PSGL-1. J Biol Chem. 2001 Dec 14; 276(50):47623-31.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.